Summary
Aarti Pharmalabs shares have surged over 33% in two days following strong Q1 results, which showed a 65.4% year-on-year profit increase and 38.7% revenue growth. The rally is further supported by a Rs 149-crore capital expenditure plan to expand capacity for its CDMO and intermediate businesses.